Cencora Inc. (COR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cencora Inc. (COR:NYSE), powered by AI.

Current Price
$281.46
P/E Ratio
35.1
Market Cap
54.6B
Sector
Communication Services
What is the Cencora Inc. stock price forecast?

Cencora Inc. is currently trading at $281.46. View real-time AI analysis on Alpha Lenz.

What is Cencora Inc. insider trading activity?

View the latest insider trading data for Cencora Inc. on Alpha Lenz.

What is Cencora Inc.'s P/E ratio?

Cencora Inc.'s P/E ratio is 35.1.

Cencora Inc.

NYSE · COR
$281.46+0.03(+0.01%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Cencora Inc.'s future dividend policy...
Alpha Chat Insight

Cencora Inc. trades at a P/E of 35.1 (premium valuation) with strong ROE of 144.3%. 3Y revenue CAGR of 10.4% highlights clear growth momentum.

Ask for details

Company Overview

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

CEOMr. Sundar Pichai
SectorCommunication Services
IndustryInternet Content & Information
Employees187,103

Company Statistics

FY 2025

Profile

$54.55BMarket Cap
$321.33BRevenue
0.00Shares Out
187,103Employees

Margins

3.57%Gross
1.57%EBITDA
1.22%Operating
0.70%Pre-Tax
0.49%Net

Valuation

35.10P/E
36.17P/B
0.17EV/Sales
11.50EV/EBITDA
17.01P/FCF

Growth (CAGR)

10.43%Rev 3Yr
11.09%Rev 5Yr
12.63%Op Inc 3Yr
14.11%Op Inc 5Yr
-2.02%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

2.18%ROA
144.31%ROE
3.73%ROIC

Financial Health

$4.36BCash & Cash Equivalents
$70.49BNet Debt
4283.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cencora Inc. (ticker: COR) is a company listed on NYSE in the Communication Services sector (Internet Content & Information). It has approximately 187,103 employees. Market cap is $54.6B.

The current price is $281.46 with a P/E ratio of 35.1x and P/B of 36.18x.

ROE is 144.31% and operating margin is 1.22%. Annual revenue is $321.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cencora Inc. (COR) Stock Forecast 2026 $281.46 — Price, Financials & Analyst Targets | Alpha Lenz